Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin adjunct therapy in adults with type 1 diabetes
ACTRN12619001440112Phase 3Completed
- Sponsor
- Garvan Institute of Medical Research
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in diabetes mellitus type 1 (T1D), sponsored by Garvan Institute of Medical Research. Primary endpoint: Change in hepatic insulin resistance. Started Dec 2019; status: completed.
02
Drugs
metformin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ACTRN12619001440112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001440112.